Ying Liu

28PUBLICATIONS
209CO-AUTHORS
Cancer geneticsPredictive and prognostic markersForensic epidemiologyNeurogeneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|May 22, 2026
Prevalence of Germline Pathogenic RET Variants in a Pan-Cancer Patient Population.

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Jan 29, 2026
Age-Related Germline Landscape of Endometrial Cancer: Focus on Early-Onset Cases.

Judy J Wang, Juliet Milani, Sarah Kane

|Dec 22, 2025
Subclinical Telomere Biology Disorder in Cancer Patients Heterozygous for the RTEL1 R1264H Founder Variant.

Lauren G Banaszak, Elise Fiala, Ozge Ceyhan-Birsoy

|Jul 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer.

Andrew McPherson, Ignacio Vázquez-García, Matthew A Myers

|Jan 16, 2025
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis.

Ying L Liu, Cara A Mathews, Fiona Simpkins

Pageof 5

Frequent Collaborators

13 joint publications

Britta Weigelt

12 joint publications

Yelena M Kemel

12 joint publications

Alicia Latham

10 joint publications

Kenneth Offit